高级检索
当前位置: 首页 > 详情页

Synergistic Toll-like Receptor 3/9 Signaling Affects Properties and Impairs Glioma-Promoting Activity of Microglia

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE ◇ 自然指数

单位: [1]Helmholtz Assoc, Max Delbruck Ctr Mol Med, Cellular Neurosci, D-13125 Berlin, Germany [2]Charite, D-10117 Berlin, Germany [3]Huazhong Univ Sci & Technol,Tongji Med Coll,Tongji Hosp,Dept Neurosurg,Wuhan 430030,Hubei,Peoples R China [4]Univ Med Ctr Schleswig Holstein, Dept Neurosurg, D-24105 Kiel, Germany [5]Charite, Inst Cell Biol & Neurobiol, Dept Neurol, D-10117 Berlin, Germany [6]Johns Hopkins Sch Med, Russell H Morgan Dept Radiol & Radiol Sci, Baltimore, MD USA [7]Charite Univ Med Berlin, Dept Radiol, D-13353 Berlin, Germany [8]Free Univ Berlin, D-13353 Berlin, Germany [9]Humboldt Univ, D-13353 Berlin, Germany [10]Berlin Inst Hlth, D-13353 Berlin, Germany
出处:
ISSN:

关键词: brain macrophage costimulation glioma microglia Toll-like receptor 3 Toll-like receptor 9

摘要:
In murine experimental glioma models, TLR3 or TLR9 activation of microglial/macrophages has been shown to impair glioma growth, which could, however, not been verified in recent clinical trials. We therefore tested whether combined TLR3 and TLR9 acti-vation of microglia/macrophages would have a synergistic effect. Indeed, combined TLR3/TLR9 activation augmented the suppression of glioma growth in organotypic brain slices from male mice in a microglia-dependent fashion, and this synergistic suppression depended on interferon b release and phagocytic tumor clearance. Combined TLR3/TLR9 stimulation also augmented several func-tional features of microglia, such as the release of proinflammatory factors, motility, and phagocytosis activity. TLR3/TLR9 stimulation combined with CD47 blockade further augmented glioma clearance. Finally, we confirmed that the coactivation of TLR3/TLR9 also augments the impairment of glioma growth in vivo. Our results show that combined activation of TLR3/TLR9 in microglia/macro-phages results in a more efficient glioma suppression, which may provide a potential strategy for glioma treatment.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2019]版:
大类 | 2 区 医学
小类 | 2 区 神经科学
最新[2025]版:
大类 | 2 区 医学
小类 | 2 区 神经科学
JCR分区:
出版当年[2018]版:
Q1 NEUROSCIENCES
最新[2023]版:
Q1 NEUROSCIENCES

影响因子: 最新[2023版] 最新五年平均 出版当年[2018版] 出版当年五年平均 出版前一年[2017版] 出版后一年[2019版]

第一作者:
第一作者单位: [1]Helmholtz Assoc, Max Delbruck Ctr Mol Med, Cellular Neurosci, D-13125 Berlin, Germany [2]Charite, D-10117 Berlin, Germany
通讯作者:
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:426 今日访问量:0 总访问量:410 更新日期:2025-04-01 建议使用谷歌、火狐浏览器 常见问题

版权所有:重庆聚合科技有限公司 渝ICP备12007440号-3 地址:重庆市两江新区泰山大道西段8号坤恩国际商务中心16层(401121)